Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.23 is 45% below its 5-year average of 2.25, near the low end of its 5-year range (1.23–3.67).
As of the fiscal period ended Tuesday, June 30, 2026. 11.79% below its 12-month average of 1.39.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.23.
CURRENT RATIO
1.23
CURRENT RATIO AVG TTM
1.39
CURRENT RATIO AVG 3Y
1.74
CURRENT RATIO AVG 5Y
2.25
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.79%
CURRENT VS 3Y AVG
-29.37%
CURRENT VS 5Y AVG
-45.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.10
median of 445 covered companies
CURRENT VS SECTOR MEDIAN
-60.34%
vs the sector median at left
Market Cap
$1.87B
Current Ratio
10.22
TTM Avg
11.68
3Y Avg
12.23
5Y Avg
12.24
Market Cap
$1.78B
Current Ratio
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.78B
Current Ratio
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.76B
Current Ratio
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.96B
Current Ratio
3.84
TTM Avg
3.30
3Y Avg
3.38
5Y Avg
3.69
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Astrana Health, Inc. (ASTH) | $1.83B | 1.23 | 1.39 | 1.74 | 2.25 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | 10.22 | 11.68 | 12.23 | 12.24 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 8.30 | 3.78 | 3.78 | 3.78 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 6.65 | 5.42 | 7.28 | 7.47 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.70 | 1.79 | 1.95 | 2.14 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 1.63 | 1.31 | 1.40 | 1.40 |
| Absci Corporation (ABSI)vs › | $1.95B | 10.63 | 5.62 | 5.37 | 6.14 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | 3.84 | 3.30 | 3.38 | 3.69 |
| Azenta, Inc. (AZTA)vs › | $1.97B | 2.50 | 3.53 | 6.11 | 4.96 |
Current Ratio
1.23
Quick Ratio
1.23
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.23 |
| 2026-03-31 | 1.35 |
| 2025-12-31 | 1.40 |
| 2025-09-30 | 1.40 |
| 2025-06-30 | 1.59 |
| 2025-03-31 | 1.70 |
| 2024-12-31 | 1.75 |
| 2024-09-30 | 1.91 |
| 2024-06-30 | 1.84 |
| 2024-03-31 | 1.51 |
| 2023-12-31 | 2.11 |
| 2023-09-30 | 2.35 |
| 2023-06-30 | 2.50 |
| 2023-03-31 | 2.76 |
| 2022-12-31 | 2.88 |
| 2022-09-30 | 2.84 |
| 2022-06-30 | 2.49 |
| 2022-03-31 | 2.77 |
| 2021-12-31 | 3.53 |
| 2021-09-30 | 3.66 |
| 2021-06-30 | 3.67 |
